These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34159217)

  • 21. Prescribing patterns of buprenorphine waivered physicians.
    Thomas CP; Doyle E; Kreiner PW; Jones CM; Dubenitz J; Horan A; Stein BD
    Drug Alcohol Depend; 2017 Dec; 181():213-218. PubMed ID: 29096292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
    Andrilla CHA; Moore TE; Patterson DG; Larson EH
    J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?
    Taylor LE; Maynard MA; Friedmann PD; Macleod CJ; Rich JD; Flanigan TP; Sylvestre DL
    J Addict Med; 2012 Sep; 6(3):179-85. PubMed ID: 22614935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine.
    Nguemeni Tiako MJ; Culhane J; South E; Srinivas SK; Meisel ZF
    JAMA Netw Open; 2020 Dec; 3(12):e2029043. PubMed ID: 33306115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between hepatitis C virus and opioid use while in buprenorphine treatment: preliminary findings.
    Murphy SM; Dweik D; McPherson S; Roll JM
    Am J Drug Alcohol Abuse; 2015 Jan; 41(1):88-92. PubMed ID: 25490610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
    Andrilla CHA; Coulthard C; Patterson DG
    Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice Predictors of Buprenorphine Prescribing by Family Physicians.
    Peterson LE; Morgan ZJ; Borders TF
    J Am Board Fam Med; 2020; 33(1):118-123. PubMed ID: 31907252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.
    Patrick SW; Faherty LJ; Dick AW; Scott TA; Dudley J; Stein BD
    JAMA; 2019 Jan; 321(4):385-393. PubMed ID: 30694320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine prescribing practice trends and attitudes among New York providers.
    Kermack A; Flannery M; Tofighi B; McNeely J; Lee JD
    J Subst Abuse Treat; 2017 Mar; 74():1-6. PubMed ID: 28132694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Needle Exchange Program on Maternal Hepatitis C Virus Prevalence.
    Rossi RM; Brady MJ; Hall ES; Warshak CR
    Am J Perinatol; 2020 Jul; 37(9):881-889. PubMed ID: 31962347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder.
    Nguyen T; Andraka-Christou B; Simon K; Bradford WD
    JAMA Netw Open; 2019 Dec; 2(12):e1916520. PubMed ID: 31790568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States.
    Lin LA; Knudsen HK
    Ann Fam Med; 2019 May; 17(3):212-220. PubMed ID: 31085525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.
    Deyo-Svendsen M; Cabrera Svendsen M; Walker J; Hodges A; Oldfather R; Mansukhani MP
    J Prim Care Community Health; 2020; 11():2150132720931720. PubMed ID: 32507023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between buprenorphine/naloxone and high-dose opioid analgesic prescribing in Kentucky, 2012-2017.
    Luu H; Slavova S; Freeman PR; Lofwall M; Browning S; Slade E; Bush H
    Drug Alcohol Depend; 2019 Dec; 205():107606. PubMed ID: 31606590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends and Patterns of Opioid Analgesic Prescribing: Regional and Rural-Urban Variations in Kentucky From 2012 to 2015.
    Luu H; Slavova S; Freeman PR; Lofwall M; Browning S; Bush H
    J Rural Health; 2019 Jan; 35(1):97-107. PubMed ID: 29664203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine.
    Andrilla CHA; Jones KC; Patterson DG
    J Rural Health; 2020 Mar; 36(2):187-195. PubMed ID: 31650634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes.
    Khan A; Khan Q; Kolb E
    J Subst Abuse Treat; 2021 Apr; 123():108256. PubMed ID: 33612191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.
    Ogbuagu O; Friedland G; Bruce RD
    Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):721-31. PubMed ID: 27140427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.